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ABSTRACT Based on atomic force microscopy analysis of the morphology of ﬁbrillar species formed during ﬁbrillation of
a-synuclein, insulin, and the B1 domain of protein G, a previously described model for the assembly of amyloid ﬁbrils of
immunoglobulin light-chain variable domains is proposed as a general model for the assembly of protein ﬁbrils. For all of the
proteins studied, we observed two or three ﬁbrillar species that vary in diameter. The smallest, protoﬁlaments, have a uniform
height, whereas the larger species, protoﬁbrils and ﬁbrils, have morphologies that are indicative of multiple protoﬁlaments
intertwining. In all cases, protoﬁlaments intertwine to form protoﬁbrils, and protoﬁbrils intertwine to form ﬁbrils. We propose that
the hierarchical assembly model describes a general mechanism of assembly for all amyloid ﬁbrils.
INTRODUCTION
Amyloidosis is characterized by extracellular protein de-
posits that form ﬁbrils either in the brain or other organs
(Cohen and Jones, 1991). Fibrils from different proteins have
surprisingly similar structures on the nanometer scale.
Typical ﬁbrils exhibit enhanced ﬂuorescence of the dye
thioﬂavin T (TfT) upon binding, range between 6 and 10 nm
in diameter, and show intertwined appearance in negatively
stained transmission electron microscope (EM) images
(Malinchik et al., 1998). Subﬁbrillar species, observed at
early time points in the aggregation, are believed to assemble
into the endpoint ﬁbrils (Goldsbury et al., 1999; Harper et al.,
1997; Ionescu-Zanetti et al., 1999).
In recent years, a number of proteins that are not related to
disease have been shown to form amyloid ﬁbrils in vitro
including acylphosphatase (Chiti et al., 2000), cold-shock
protein (Wilkins et al., 2000), hen lysozyme (Krebs et al.,
2000), B1 domain of protein G (Ramirez-Alvarado et al.,
2000), SH3 domain (Zurdo et al., 2001), cytochrome c
(Pertinhez et al., 2001), and myoglobin (Fandrich et al.,
2001). Each system in which amyloidogenesis can be
induced in vitro gives valuable information on the un-
derlying principles of ﬁbril formation. For example, amyloid
ﬁbrils are postulated to have high b-sheet content, but native
myoglobin contains no b-sheets, whereas insulin has only
a small b-strand; this suggests that for these proteins, the
secondary structure changes from a to b during conversion
to amyloid. Other model systems such as the B1 domain of
protein G are important because of our detailed understand-
ing of their folding dynamics.
Amyloid ﬁbril formation generally is a result of alteration
of the native conformation. This has been demonstrated for
many proteins such as b-amyloid (Ab) peptides (Barrow and
Zagorski, 1991), transthyretin (Kelly et al., 1997), b2-
microglobulin (McParland et al., 2000), lysozyme (Booth
et al., 1997), SH3 domain (Zurdo et al., 2001), and im-
munoglobulin light chains (Khurana et al., 2001). Natively
unfolded a-synuclein also undergoes a transition to a
partially folded intermediate before ﬁbril formation, again
suggesting a role of alternate conformation in ﬁbrillation
(Uversky et al., 2001). Partially folded conformations are
favored by mutations or changes in the pH and ionic strength
and are thought to be critical intermediates in the transition to
amyloid ﬁbrils.
The atomic force microscope (AFM) has been used to
study the morphology of amyloid ﬁbrils in various proteins
including Ab (Harper et al., 1997; Stine et al., 1996;
Blackley et al., 2002), a-synuclein (Conway et al., 2000;
Rochet et al., 2000), amylin (Goldsbury et al., 1999), SH3
domain and lysozyme (Chamberlain et al., 2000), and b2-
microglobulin (Kad et al., 2001). Detailed kinetic studies of
the ﬁbrillogenesis were previously performed for the vari-
able domain of immunoglobulin light chain (Ionescu-Zanetti
et al., 1999) using the AFM to identify the species involved
in the assembly process, and a hierarchical assembly model
(HAM) was proposed to describe the formation of the ﬁbrils
from smaller subspecies. In the present study, the AFM was
used to study the morphology of ﬁbrillar species at early and
later time points in the protein-aggregation process of three
proteins: a-synuclein, insulin, and the B1 domain of protein
G. Our results, combined with the data from a number of
other structural studies of amyloid proteins, suggest that the
previously proposed HAM is of general applicability to
amyloid ﬁbril assembly.
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The hierarchical assembly model
The essence of this model is that protoﬁlaments form through
a nucleated polymerization kinetic model in which the
nascent protoﬁlaments elongate through the addition of mo-
nomeric, partially folded intermediates to the ends of the
growing protoﬁlaments. The rodlike protoﬁlaments then
interact with one another to form protoﬁbrils consisting of
two (and occasionally three) intertwined protoﬁlaments.
Finally, two protoﬁbrils intertwine to form mature ﬁbrils.
The protoﬁbrils and ﬁbrils will be much more rigid than the
protoﬁlaments, leading to straight, rodlike structures. The
driving force for the interactions of protoﬁlaments to pro-
toﬁbrils, and protoﬁbrils to ﬁbrils, as well as the clumping of
ﬁbrils, which is often observed, arises from the surface of the
protoﬁlaments and involves both hydrophobic and electro-
static interactions. The HAM model predicts that at early
times in ﬁbrillation, the predominant ﬁbrillar species will be
protoﬁlaments, whereas at later times, only protoﬁbrils and
ﬁbrils will be observed. The HAM model predicts that
protoﬁbrils and ﬁbrils will exhibit periodicity, as well as
potential variations in height due to uneven overlap of the
constituent ﬁbrillar species. The periodicity will be a function
of the stiffness of the protoﬁlaments and protoﬁbrils. For
calcitonin, however, ribbon-shaped ﬁbrils are observed,
possibly suggesting that some protoﬁlaments may just
interact lengthwise and not necessarily intertwine. The
length of the protoﬁlaments is likely determined by the net
kinetics of association (elongation) and dissociation of the
monomers to the ends of the protoﬁlaments. If protoﬁlaments
of different lengths intertwine to form a protoﬁbril, mono-
mers can add to the shorter protoﬁlament to ‘‘ﬁll in’’ the
protoﬁbril. The HAMmodel also predicts potential branched
ﬁbrillar species; for example, the interaction of two
protoﬁbrils to form a ﬁbril could be incomplete, possibly
due to intertwining of protoﬁbrils of varying lengths. All of
these predictions are borne out in our reported observations.
METHODS
Amyloid ﬁbril formation
a-Synuclein
a-Synuclein (140 amino acids (AA)) was expressed and puriﬁed by fusing
its gene into an intein/chitin-binding domain system (Impact T7 system from
New England Biolabs, Beverly, MA) and expressing the fusion protein in
Escherichia coli (Uversky et al., 2001). The purity of the resultant protein
was assessed by polyacrylamide gel electrophoresis and electrospray mass
spectrometry.
A 1.0-mg/mL a-synuclein solution at pH 7.5 in 20 mM Tris, 100 mM
NaCl buffer was stirred at 378C in glass vials with micro stir bars. The a-
synuclein solutions were also stirred in the presence of 20–50 mM heparin.
Fibril formation started after 24 h and was complete by 36 h as monitored by
enhanced TfT ﬂuorescence. We carefully chose conditions where amor-
phous aggregates and small b-sheet aggregates were not observed, to
exclude TfT binding to those intermediates. The presence of ﬁbrils was
conﬁrmed by electron microscopy (negative staining with uranyl acetate,
data not shown (Uversky et al., 2001)).
Insulin
Puriﬁed bovine insulin (51 AA) was provided by Novo Nordisk
(Copenhagen, Denmark). Bovine insulin (1 mg/mL) was incubated in 100
mM HCl at pH 1.6 with gentle stirring at 378C. Fibril formation was
monitored for 1–4 h by enhancement in TfT ﬂuorescence in a 10-mM TfT
solution of 100 mM Tris. In HCl, insulin exists as a dimer as conﬁrmed by x-
ray scattering studies (Nielsen et al., 2001). Again amorphous or other
aggregates were not observed at low pH for insulin, and ﬁbril formation was
the major pathway. At every hour, 10-mL aliquots of sample were diluted
10-fold to a ﬁnal concentration of 0.1 mg/mL before deposition on mica.
B1 domain of protein G
The B1 domain of protein G was expressed and puriﬁed following published
procedures (Smith et al. 1994). Brieﬂy, ion-exchange chromatography (Q-
Sepharose) in a gradient of NaCl in 20 mM Tris-HCl buffer (pH 8.0) was
followed by gel-ﬁltration chromatography (Hi-Load Superdex 75, Amer-
sham Pharmacia, Uppsala, Sweden) in 50 mM sodium acetate (pH 5.2).
Protein purity was checked by polyacrylamide gel electrophoresis, and the
protein concentration was determined from the amino acid analysis
performed at the Howard Hughes Medical Institute Biopolymer Laboratory
and W.M. Keck Foundation Biotechnology Resource Laboratory at Yale
University. Fibril formation was complete by 36 h as monitored by enhanced
TfT ﬂuorescence. For B1 protein, we started with monomeric protein as
conﬁrmed by x-ray crystallography and did not observe aggregates other
than ﬁbrils.
AFM imaging
The samples were imaged with an AutoProbe CP AFM (Park Scientiﬁc,
Sunnyvale, CA). In the AFM, a laser beam is reﬂected from the top of a small
metal cantilever into a split photodiode. When the sharp tip of the cantilever
(radius  10 nm) comes into contact with the sample, the deﬂection of the
laser beam can be detected by the difference in the signal from the top and
bottom halves of the photodiode. A piezoelectric tube raster scans the
sample underneath the tip; it also moves the sample up and down to keep the
deﬂection of the cantilever constant. AFM images are obtained by plotting
the zmovement as a function of x,y position. The tube scanner was a 100-mm
ScanMaster (ThermoMicroscopes). Noncontact Ultralevers (ThermoMicro-
scopes) were used as cantilevers. Samples were prepared for AFM imaging
by drying a 5-ml sample from the reaction mixture on freshly cleaved mica
with nitrogen gas. The drying process was less than a minute and did not
affect the aggregation status of the sample, because the protoﬁlament
elongation and intertwining occurred over several hours. The buffer and salt
components were washed from the surface of the mica with double-distilled
water, and the mica was dried again. This procedure ensured that the ﬁbrils
and protein molecules remained attached to the mica surface possibly due to
the slight negative charge on the mica.
The images shown in Figs. 1, 4, and 7 were taken in the noncontact AFM
(NC-AFM) imaging mode. NC-AFM is an imaging mode in which the
cantilever is set vibrating in the z direction at its resonant frequency of;100
kHz. The proximity of the sample results in a dampening of the amplitude of
vibration of the cantilever. The piezoelectric raster scans the sample and
moves it in the z direction to keep the amplitude of vibration constant. The
advantage of the NC-AFM imaging mode over the conventional AFMmode
described above (contact mode) is that in the former, the tip-sample forces
are greatly reduced, which reduces the damage to biological samples. Images
were taken in air under ambient conditions at a scan frequency of 1–2 Hz.
Due to the shape of the AFM tip, AFM measurements typically result in
broadened widths; however, the shape of the tip does not affect the z-axis
measurements. Therefore, accurate heights of ﬁbril species can be deter-
mined from AFM measurements. The resolution of the height measurement
is mainly limited by the z-axis noise, which is normally a few tenths of
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a nanometer under standard imaging conditions. The accuracy of the height
measurements is limited by tip-sample interactions that are a function of the
imaging conditions; these effects are discussed in more detail (see General
characteristics).
Height analysis
Height measurements were made from scan sizes of 5 3 5 mm or less by
measuring height proﬁles normal to the ﬁbril axis over a region greater than
the periodicity of height variations and averaging the peak height of the
proﬁle. Heights for the different ﬁbril species were obtained by averaging
measurements from a large number of individual ﬁbrils ([25), with errors
being calculated as one standard deviation (1 s) from the mean. Fibril
periodicity was determined by scanning a line along the length of a ﬁbril and
averaging the distance measured between two high points. Measurement
results are summarized in Table 1.
RESULTS AND DISCUSSION
To elucidate the mechanism of amyloid ﬁbril formation, the
kinetics of ﬁbril formation were monitored by NC-AFM.
Samples from both early and late time points in the ﬁbril-
formation process were imaged to identify all of the
subspecies that are involved. For all three proteins (a-
synuclein, insulin, and B1 domain), a very thin species was
observed at early time points and classiﬁed as a protoﬁla-
ment. At intermediate times, protoﬁbrils, which showed
periodic variations in height, were abundant. At longer times,
mature ﬁbrils were preponderant. Because thioﬂavin-T binds
to both protoﬁbrils and ﬁbrils, our later time points are not
necessarily at the endpoint of the ﬁbril-formation process;
this explains why protoﬁbrils are still observed.
Protoﬁlament, protoﬁbril, and ﬁbril dimensions are
presented in Table 1. The observations are consistent with
the hierarchical assembly model, in which mature amyloid
ﬁbrils are assembled by the intertwining of precursor pro-
toﬁlaments and protoﬁbrils. For other proteins, a number of
groups have also observed that the mature ﬁbrils result from
intertwining of smaller ﬁbrillar species: for Alzheimer’s b
(1–40) and (1–42), respectively), the intertwining of pro-
toﬁlaments (2.5–3.0 nm in diameter) into ﬁbrils has been ob-
served (Harper et al., 1997; Malinchik et al., 1998).
Several groups have suggested that amyloid ﬁbrils are
formed from partially folded intermediate states (Barrow and
Zargorski, 1991; Kelly et al., 1997; Booth et al., 1997;
Khurana et al., 2001; Uversky et al., 2001). The B1 domain
of protein G has been shown to have the greatest propensity
to form ﬁbrils when there are many intermediate states
sampled during the unfolding transition (Ramı´rez-Alvarado
et al., 2000). For a-synuclein (Uversky et al., 2001) and
insulin (Nielsen et al., 2001), changes from their unfolded
and native conformations, respectively, are essential before
the formation of amyloid ﬁbrils. In the present work, stir-
ring of the proteins under different conditions of pH and
temperature led to in vitro ﬁbril formation, which was
monitored by enhanced ﬂuorescence of TfT. Various con-
ditions lead to nonnative conformations due to partial un-
folding of proteins with exposed hydrophobic regions that
are normally masked in the native conformation. Our results
suggest that the nonnative monomers interact with each other
and form protoﬁlaments. We observe elongation of protoﬁla-
ments at early time points. After the initial elongation, the
average lengths of protoﬁlaments do not change much. In
fact, the average protoﬁlament length is comparable to the
average lengths of protoﬁbrils and ﬁbrils.
The protoﬁlaments intertwine into protoﬁbrils, and these
in turn intertwine to form ﬁbrils. Protoﬁlaments may in-
tertwine to form protoﬁbrils in an effort to minimize the
exposure of their hydrophobic regions. We note that our data
does not necessarily preclude the possibility that new pro-
toﬁlaments templating off the sides of existing protoﬁla-
ments. The periodicity observed in protoﬁbrils is expected to
be driven by a balance between mechanical forces dominated
by the elasticity of the protoﬁlament and the electrostatic
forces due to the distribution of hydrophobic regions and
charges along the protoﬁlament backbone. Protoﬁbrils
TABLE 1 Dimensions of ﬁbrillar species observed by AFM for four different proteins
Protein Protoﬁlaments (nm)* Protoﬁbrils/ﬁbrils (nm)y
Amino acid content
(monomer dimensions)z
a–Synuclein 3.8 6 0.6 6.5 6 0.6 (100–150 nm)
9.8 6 1.2
140 aa (natively unfolded,
dimensions not available)
Insulin 1.2 6 0.3 1.9 6 0.3
3.0 6 0.4, 4.8 6 0.4
51 aa (3.1 3 3.3 3 2.2 nm)
B1 domain of protein G 1.9 6 0.9 3.9 6 0.3, 5.2 6 0.3 58 aa (3.5 3 2.2 3 2.0 nm)
Ig variable-domain SMA§ 2.5 6 0.4 4.5 6 0.5, 5.9 6 0.6,
8.0 6 1.0 (60 nm, 110 nm)
114 aa (4.0 3 2.5 3 1.4 nm)
*Protoﬁlament diameters as inferred from protoﬁlament average-height measurements plotted as histograms, and the smallest peak height from the
histograms in Figs. 2, 5, and 7 is estimated as protoﬁlament diameter.
yDiameter measurements for higher-order species protoﬁbrils/ﬁbrils, also derived from the histogram peaks. In parenthesis are the periodicities of some
species, where available.
zThe amino acid count for each of the proteins and the dimensions of the natively folded conformation, as measured by x-ray crystallography or NMR
techniques.
§SMA, initials of the patient whose sequence was used to clone the gene coding for variable domain of Ig light chain.
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presumably intertwine to form ﬁbrils to further minimize ex-
posure of hydrophobic regions.
In the following sections, we give a detailed description of
ﬁbril formation for each of the three proteins studied.
a-Synuclein
The a-synuclein ﬁbrils varied in length from;500 nm to 2.5
mm (Fig. 1, A and B). Fig. 1 A shows a typical protoﬁbril of
a-synuclein with an average height of 6.5 nm with high (red
arrow) and low (blue arrow) points of 7.2 and 5.8 nm,
respectively. In our preparations, protoﬁbrils also show
evidence of intertwining with a periodicity of 100–150 nm
and an amplitude (difference in height between high and low
points) of;1 nm (Fig. 1 A). Protoﬁlaments, (Fig. 1 A, inset),
protoﬁbrils (Fig. 1 B, red arrow), and ﬁbrils (Fig. 1 B, blue
arrow) were observed in a variety of different kinetic runs
and different samples imaged. A histogram of the heights
observed is presented in Fig. 2. The heights of the ﬁbrils
observed can be classiﬁed into three categories: protoﬁla-
ments, 3.8 6 0.6 nm; protoﬁbrils, 6.5 6 0.6 nm; and ﬁbrils,
9.8 6 1.2 nm (Fig. 2, arrows). Protoﬁlaments (3.8-nm
species) were only observed under conditions where heparin
was present while stirring a-synuclein solutions (Fig. 2, solid
bars), and portions of protoﬁlaments were most likely
covered with heparin molecules. It is possible that charges
on synuclein molecules bind heparin molecules and get
stabilized as protoﬁlaments, whereas in the absence of hep-
arin, the protoﬁlaments are highly charged and quickly inter-
twine with other protoﬁlaments to yield stable protoﬁbrils
(6.5-nm species) that are readily observed under all condi-
tions. We note that comparable heights for a-synuclein ﬁbrils
(between 8 and 9 nm) were observed when imaged in water
rather than air (J. Li, M. Zhu, A. Manning-Bog, A. Donato,
D. DiMonte, A. L. Fink, unpublished observations.
Rochet et al. (2000) also looked at ﬁbril morphology and
observed one ﬁbril species that shows periodicity along the
ﬁbril and is 7.6 6 0.6 nm at the high points. This species
appears to be equivalent to our protoﬁbrils, which are ;7.2
nm at the high points and have an average height of 6.56 0.6
nm (see Fig. 1A). Rochet and co-workers also observed
ﬁbrils of 12.1 6 0.9 nm in diameter by EM (Rochet et al.,
2000), which might correspond to the ﬁbrils we observed by
AFM, with an average height of 9.8 6 1.2 nm.
The hierarchical assembly model postulates that higher-
order ﬁbrils result from the intertwining of a number of
protoﬁlaments that behave like stiff rods, having a period-
icity to diameter ratio of ;10. In this scheme, protoﬁbrils
would be a result of the intertwining of two protoﬁlaments.
Thus the high points of protoﬁbril will be 2D (where D is
FIGURE 1 AFM images of a-synuclein ﬁbrillar aggregates. (A) The
observed periodicity of 100–150 nm along the protoﬁbril is shown. The peak
(red arrow) to trough (blue arrow) height difference was ;1 nm, and the
average protoﬁbril diameter was 6 nm. (A, inset) A section of a protoﬁlament
with an average height of 3.8 nm. (B) A number of juxtaposed ﬁbrillar
species: protoﬁbrils of 6.5 nm in height (red arrow) and ﬁbrils of 9.8 nm in
height (blue arrow) are shown adsorbed to the substrate.
FIGURE 2 A histogram of height distributions of the observed a-
synuclein ﬁbrillar species for a number of early and later time points. The
three peaks correspond to: (A) 3.8-nm protoﬁlaments, (B) 6.5-nm proto-
ﬁbrils, and (C) 9.8-nm ﬁbrils.
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the protoﬁlament diameter), whereas the low points will be
;1.5D (due to the stiffness and intertwining, the protoﬁla-
ments are most likely raised from the surface of mica at
the low points), resulting in the measured average height of
protoﬁbrils at 1.75D. For a-synuclein data, the protoﬁlament
diameter D is 3.8 nm, yielding an average protoﬁbril
diameter of 6.65 nm. This is in excellent agreement with
the measured protoﬁbril height of 6.5 6 0.6 nm. Similarly,
intertwining of two protoﬁbrils (6.5 nm in diameter) gives an
average ﬁbril height of 11 nm, which is also within s
of the measured value (Fig. 2). This agreement of height
measurements, together with the evidence of height var-
iations for the protoﬁbrils and ﬁbrils, suggests a good ﬁt
of a-synuclein ﬁbril assembly to the protoﬁlament-intertwin-
ing model. A schematic diagram of the resulting paradigm
for assembly of a-synuclein into ﬁbrils is presented in Fig. 3.
Insulin
Insulin ﬁbrils were formed in vitro by stirring the protein in
an acid solution (pH 1.6). Under these conditions, insulin
ﬁbrils reach maturity after 4 h of incubation, after which no
further enhancement of TfT ﬂuorescence is observed. In the
1-h incubations, protoﬁlaments (1.2 6 0.3 nm in diameter,
red arrows), protoﬁbrils (1.9 6 0.3 nm, blue arrows), and
ﬁbrils (3.0 6 0.4 nm) are observed (Fig. 4 A). After 3 h of
incubation, both ﬁbrils (green arrows) and protoﬁbrils (blue
arrows) are observed, but no protoﬁlaments (Fig. 4B). Large
bundles of ﬁbrils (Fig. 4B, white arrow) were also observed.
EM studies of insulin ﬁbrillation report ﬁbril diameter
ranging from 3 to 15 nm (Brange et al., 1997). In some cases,
protoﬁbrils (3 nm) are seen to bundle together in groups of
2–5 and yield mature ﬁbrils that are 10–15 nm in diameter
(Brange et al., 1997).
Our AFM measurements of different ﬁbrillar species of
insulin are summarized in the histogram of Fig. 5. The
histogram of average ﬁbril heights contains data from both
the 1- and 3-h incubations, which are identiﬁed as solid and
open bars, respectively, in Fig. 5. Peaks in the distribution
are taken to be the height of each of the ﬁbrillar species (Fig.
5, arrows). The lowest peak is at 1.2 6 0.3 nm and
corresponds to protoﬁlaments. Because the height of the
protoﬁlaments is lower than the dimensions of globular
natively folded insulin, we conclude that the monomers
incorporated into protoﬁlaments have undergone structural
changes from the native conformation. It should be noted,
however, that dimensions may be underestimated by NC-
FIGURE 3 A model for the hierarchical assembly of a-synuclein into
amyloid ﬁbrils. Protoﬁlament pairs wind together to form protoﬁbrils, and
each two protoﬁbrils wind to form a ﬁbril.
FIGURE 4 AFM images of insulin ﬁbrillar species at two different time
points of aggregation. (A) Protoﬁlaments (1.2 nm, red arrows) and
protoﬁbrils (1.9 nm, blue arrows) present after 1 h of incubation. Proto-
ﬁlament intertwining to form protoﬁbrils is also observed ( yellow
arrow). (B) Protoﬁbrils (1.9 nm, blue arrows) and ﬁbrils of various
dimensions (green arrows) present after 3 h of incubation. A ﬁbril bundle of
50 nm height is also present (white arrow).
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AFM imaging in air due to deformation of the biomolecule
by the AFM tip; this effect is discussed further in General
characteristics.
Protoﬁbrils, the next stage in ﬁbril assembly, are observed
to result from the intertwining of two protoﬁlaments as
shown in Fig. 4A (yellow arrow). Many of the ﬁbrils
observed correspond to a protoﬁlament height in one region
and a protoﬁbril at one end, which is presumably a result of
the intertwining of two protoﬁlaments of unequal length.
Although protoﬁbrils and ﬁbrils are essentially straight
over long distances ([500 nm), protoﬁlaments are less rigid
and often have a radius of curvature of ;400 nm (Fig. 4A,
red arrows). Clearly, much of the rigidity of the mature
ﬁbrils is a result of the increased stiffness due to winding of
protoﬁbrils and protoﬁlaments. If two protoﬁlaments in-
tertwine together to form a protoﬁbril, the model predicts
average protoﬁbril heights of 1.75D (where D is the insulin
protoﬁlament height of 1.2 nm) or 2.1 nm. This can be
identiﬁed as the species observed by AFM of 1.9 6 0.3 nm
in height. Two sizes of mature ﬁbrils were observed:
a smaller ﬁbril of 3.0 6 0.4 nm in diameter, corresponding
to the intertwining of two protoﬁbrils (and predicted to have
a diameter of 3.3 nm) and a larger-diameter ﬁbril of 4.8 6
0.4 nm in diameter. We identify these as types I and II ﬁbrils,
respectively. The type II ﬁbrils can be explained by the
intertwining of two type I ﬁbrils, which would be predicted
to give a ﬁbril with a diameter of 5.2 nm. This proposed
hierarchical assembly is shown in Fig. 6.
B1 domain of protein G
The B1 domain of the Ig-binding domain of protein G (b1,
58 AA) is a very well-characterized model system for
structural, kinetic, and thermodynamic properties. As shown
in previous work (Ramı´rez-Alvarado et al., 2000), some
variants of B1 form ﬁbrils with high reproducibility. It was
found that the key requirement for ﬁbril formation is to
choose conditions in which the population of intermediate
conformations present during the unfolding transition is
maximized (Ramı´rez-Alvarado et al., 2000). As our model
system, we chose B1 variants (G6Y53, I6T53) that lead to
reproducible ﬁbril formation. Both variants formed ﬁbrils
that were indistinguishable from one another by the AFM.
As for a-synuclein and insulin, we observed small
protoﬁlaments for B1 variants at early times in the ag-
gregation (24 h; Fig. 7 A) that were 1.9 6 0.9 nm in diam-
eter. At the completion of ﬁbrillation (as determined by no
further increase in ﬂuorescence of TfT, 36 h), there were two
ﬁbrillar species: we consider the species with a diameter of
3.9 6 0.3 nm to be protoﬁbrils and the species with
a diameter of 5.26 0.3 nm to be ﬁbrils. Both protoﬁbrils and
ﬁbrils can be observed in Fig. 7 B, an AFM micrograph at
36 h. Each species can be seen as a peak in the height-
distribution histogram of Fig. 8 (arrows).
Following our postulate that the ﬁnal ﬁbrils are a result of
protoﬁlament winding, simple geometrical considerations
lead us to conclude that protoﬁbrils are formed by three
protoﬁlaments wound together. Fibrils involve six protoﬁla-
ments, or two protoﬁlaments wound together with a hexag-
onal cross section leading to a hollow core, as observed for
FIGURE 5 The height distributions of insulin ﬁbrillar species are divided
into two parts. Measurements of images taken at an early time point (1 h)
contain mostly protoﬁlaments (1.2 nm) and protoﬁbrils (1.9 nm). At a later
time point (3 h), only ﬁbrils of various dimensions are observed. Peaks in the
distribution correspond to: (A) protoﬁlaments, (B) protoﬁbrils, (C) type I
ﬁbrils, and (D) type II ﬁbrils.
FIGURE 6 A model for the hierarchical assembly of insulin into amyloid
ﬁbrils. Protoﬁlament pairs wind together to form protoﬁbrils, and each two
protoﬁbrils wind to form a type I ﬁbril. Type II ﬁbrils are the result of
winding of type I ﬁbrils.
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SH3 domain ﬁbrils by cryoelectron microscopy; these are
also composed of two trimeric protoﬁbrils (Jimenez et al.,
1999). In particular, three cylindrical protoﬁlaments wound
together have a maximum height of 2D (where D is the
protoﬁlament diameter) and a minimum height of 1.87D,
leading to an average height of 1.93D or 3.7 nm for pro-
toﬁbrils. For six protoﬁlaments arranged in a hexagon, the
maximum and minimum heights are 3D and 2.72D, re-
spectively, and yield an average diameter of 2.85D or 5.4
nm. The values are within 1 s of the measured diameters for
protoﬁbrils and ﬁbrils. Alternatively, the ﬁbril could be
formed by the winding together of two protoﬁbrils; however,
this would require a rearrangement to the hexagonal structure
to obtain the same heights. A diagram of the resulting
paradigm for assembly of B1 domain protein into ﬁbrils is
presented in Fig. 9. A consequence of the model is that it
would be difﬁcult to observe the periodicity in the
protoﬁbrils and the ﬁbrils, since the difference between the
high and low points along the ﬁbril length is small; this may
explain why we do not observe any clear periodicity for B1.
General characteristics
For all three proteins studied, as well as amyloidogenic Ig
light chains, we can identify a species that is dominant at
early time points in the aggregation and has a small diameter,
termed protoﬁlament. Protoﬁlament packing in the mature
ﬁbrils differs from one protein to another. Protoﬁlament
heights were measured to be from 1.2 (insulin) to 3.5 nm (a-
synuclein). We observe a rough correlation between
FIGURE 7 AFM images of ﬁbrillar species formed by the B1 domain of
protein G. (A) Protoﬁlaments (1.9 nm) are observed after incubation for 24 h.
(B) Protoﬁbrils and ﬁbrils of various diameters and lengths are observed
after incubation for 36 h.
FIGURE 8 Heights of the three different ﬁbrillar species that are present
in the B1 aggregates can be extracted from this histogram of observed ﬁbril
diameters. Measurements taken at an intermediate time point (24 h) show:
(A) 1.9-nm protoﬁlaments, (B) 3.9-nm protoﬁbrils, and (C) 5.2-nm ﬁbrils.
Measurements taken at later time points (36 h) show predominantly proto-
ﬁbrils and ﬁbrils of various diameters.
FIGURE 9 A model for the hierarchical assembly of the B1 domain of
protein G into amyloid ﬁbrils. Three protoﬁlaments wind together to form
a protoﬁbril, and two protoﬁbrils (or six protoﬁlaments) wind to form a ﬁbril.
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protoﬁlament size and protein chain length for the proteins
included in our study (Table 1). This correlation, however,
does not ﬁt other proteins such as amylin (Goldsbury et al.,
1999) and Ab (Harper et al., 1997) possibly due to varying
imaging conditions yielding different heights (see discussion
below).
Chamberlain et al. (2000) reported a detailed study on
amyloid ﬁbrils from an SH3 domain, lysozyme, and
a transthyretin peptide using AFM. This study only included
the end-time ﬁbrils but still supports our model, since ﬁbrillar
species with a broad distribution of heights as well as
intertwined ﬁbrils were observed. Chamberlain and co-
workers (2000) measured the height of ﬁbrils from a peptide
(TTR 10–19) using AFM with both air-dried and buffer
samples and also via negatively stained EM. The results for
the ﬁbril diameters vary from 6.26 1.5 nm and 5.66 0.6 nm
for EM and air NC-AFM, respectively, to as low as 4.4 nm
when imaged by NC-AFM in buffer.
These results point out a central issue in the comparison of
quantitative results from different laboratories in this ﬁeld,
namely, that although the qualitative ﬁbril-assembly process
is common to all observations, the exact dimensions of
biomolecules vary depending on the imaging conditions. To
complicate matters, careful studies of the height of bio-
molecules on mica by NC-AFM in buffer show that at least
for some biological systems, there is a sharp variability of
measured heights as a function of both electrolyte con-
centration and pH (Mu¨ller and Engel, 1997). We have chosen
to use NC-AFM in air because samples are stable for long
time periods after mica deposition ([20 weeks) and mea-
sured heights are in excellent agreement with measurements
by high-resolution EM (Ionescu-Zanetti et al., 1999). In
addition to providing stability, air drying the sample arrests
the kinetics of ﬁbril formation at desired time points.
Other important issues for the comparison of results on the
dimensions of ﬁbrillar species are the measurement and
reporting methods. Because many of the species observed
exhibit a height periodicity along the ﬁbril length, we have
performed measurements that average the ﬁbril height
over a region that represents at least one period of the
height oscillation. Also, for the ﬁnal determination of the
dimensions of ﬁbrillar species, peaks are identiﬁed in
a histogram of the observed heights, and the peak values
are reported along with the standard deviation. This is in
contrast with the common practice of simply offering
approximate dimensions without determination of the errors
involved. Greater homogeneity in the measurement proto-
cols and careful consideration of the effects of imaging
conditions on observed heights are clearly important for
meaningful comparisons of the results from a number of
different studies.
Regardless of the accuracy of the heights, it is easy to
conﬁrm the presence of subﬁbrillar species that assemble
into the mature ﬁbrils. For the three proteins studied, we
observe that the ﬁbrils are formed by the lateral association
of protoﬁlaments. Both protoﬁbrils and ﬁbrils exhibit
occasional periodic structures along the ﬁbril length,
suggesting protoﬁlaments and protoﬁbrils intertwine to
give rise to protoﬁbrils and ﬁbrils, respectively (Fig. 1 A).
The occasional observation of branch points (Figs. 1 B and
4 A) and elongation of protoﬁlaments from the ends of
protoﬁbrils and ﬁbrils (Fig. 4 A) provide additional evi-
dence for protoﬁlament winding as the primary mechanism
of ﬁbril assembly. This paradigm is also supported by the
fact that single protoﬁlaments are not observed at the
endpoints of aggregation (Figs. 2, 5, and 8). This correlates
well with observations of twisted structures, branch points,
and protoﬁlaments splaying out at the ends of ﬁbrils for
a number of systems including Ab (Harper et al., 1999;
Stine et al., 1996; Serpell et al., 2000), SH3 domain and
lysozyme (Chamberlain et al., 2000; Zurdo et al., 2001),
amylin (Goldsbury et al., 1999), and yeast Sup35 (Xu et al.,
2001). Mature ﬁbrils are routinely observed to be composed
of 2–6 protoﬁlaments. We should note here that despite
the large number of observations that point to the protoﬁla-
ment as the building block of mature ﬁbrils, this is not
a universally accepted model. For example, Xu et al. (2001)
argue that mature ﬁbrils are formed by the end-to-end
addition of large nucleation units, containing perhaps as
many as 8–10 monomers; however, it is hard to explain the
branching and twisting events that are observed using this
model.
The great height variability observed within the protoﬁbril
and ﬁbril population is attributed primarily to the different
number of constituent protoﬁlaments. In contrast, Chamber-
lain et al. (2000) ascribe the variability of ﬁbrillar heights to
the tightness of the protoﬁbrillar twist. This is based on the
interesting observation that larger-diameter ﬁbrils seem to
have a shorter periodicity along the ﬁbril length. Although it
is clear that this mode of protoﬁbril assembly also plays a role
in the ﬁnal ﬁbril morphology, it is hard to envisage that
a doubling of protoﬁbril height is due to a 50% increase in
the twist period, since a decrease in the twist period should
only bring the height peaks along the ﬁbril closer together
rather than increasing both the peak and the trough heights
along the ﬁbril.
From the large number of ﬁbrillar precursors observed,
these results suggest that the protoﬁlament is the simplest
structure and is found at the initial stages of ﬁbrillogenesis.
Therefore, we postulate that the protoﬁlaments are the ﬁrst
ordered, insoluble species with a b-sheet core assembled
from the monomeric protein. It is possible that the very
small dimensions we observe for insulin protoﬁlaments
(1.2 nm) might be actually due to their ﬂat placement on
the mica, and height measurements may not be the best
measure for the diameter of these species. X-ray ﬁber-
diffraction studies (Inouye et al., 1993; Serpell et al., 1995;
Serpell et al., 2000) suggest that the core of the ﬁbril is
composed of b-strands that run perpendicular to the axis of
the ﬁbril, and that the b-strands have a 158 twist to each
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other in the ‘‘inﬁnite’’ b-sheet that is formed in the
direction of the ﬁbril axis. Our data indicate that the
diameters of the protoﬁlaments differ for different poly-
peptides. The apparent variability in protoﬁlament dimen-
sions must be due to a combination of the length of b-
strands along with the polypeptide regions that connect the
b-strands such as loops and turns. There is evidence for
the presence of non-b-regions in amyloid ﬁbrils obtained
for various proteins from Fourier transform infrared
spectroscopy analysis (R. Khurana, K. A. Oberg, S. She-
shadri, J. Li, and A. L. Fink, unpublished observations).
The non-b-sheet regions are presumably responsible for
the interactions that drive the assembly of protoﬁlaments
into higher-order structures. Because the non-b-sheet
regions differ from one protein system to another, this
would account for the large variability observed in the
dimensions and the hierarchical assembly process for
various protoﬁlaments.
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